Similar articles

• An ounce of tuberculosis prevention.

  Kornfeld H. Kornfeld H. Chest. 2008 Apr;133(4):835-6. doi: 10.1378/chest.07-2756. Chest. 2008. PMID: 18398110 No abstract available.
• Anti-tuberculosis 4FDC tablets--mystery to chemistry.

  Dekker TG, Lötter AP. Dekker TG, et al. Int J Tuberc Lung Dis. 2003 Mar;7(3):205-6. Int J Tuberc Lung Dis. 2003. PMID: 12661831 No abstract available.
• Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

  Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE. Page KR, et al. Arch Intern Med. 2006 Sep 25;166(17):1863-70. doi: 10.1001/archinte.166.17.1863. Arch Intern Med. 2006. PMID: 17000943
• Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.

  Reichman LB, Lardizabal A, Hayden CH. Reichman LB, et al. Am J Respir Crit Care Med. 2004 Oct 15;170(8):832-5. doi: 10.1164/rccm.200405-584PP. Epub 2004 Aug 5. Am J Respir Crit Care Med. 2004. PMID: 15297274 Review. No abstract available.
• [Tuberculosis].

  Bonnaud F, Zigani A. Bonnaud F, et al. Rev Prat. 2002 Oct 15;52(16):1809-20. Rev Prat. 2002. PMID: 12564174 Review. French. No abstract available.